Direct Anterior Approach (DAA) for Total Hip Arthroplasty (THA): Capsular Resection Versus Capsular Flap Retention
NCT ID: NCT02970253
Last Updated: 2020-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
190 participants
INTERVENTIONAL
2017-11-01
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Prospective study design comparing clinical data in randomized THA patients who either had capsular resection or capsular flap retention.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does Vessel-sparing Surgery in Anterior Approach Total Hip Arthroplasty Change Clinical Outcome?
NCT06308965
The Clinical Outcomes After Direct Anterior Approach and Microposterior Approach for Total Hip Arthroplasty
NCT03210844
Consequence of the Learning Curve in Direct Anterior Approach for Total Hip Replacement
NCT02645435
Modeling and Workflow Recognition for the Anterior Approach in Total Hip Arthroplasty
NCT05993845
Effect of Capsular Repair on the Outcomes of Direct Anterior Total Hip Arthroplasty.
NCT04570748
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Capsular resection
Capsular resection
Capsular resection
Capsular resection
Capsular retention
Capsular retention
Capsular retention
Capsular retention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Capsular resection
Capsular resection
Capsular retention
Capsular retention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* painful contralateral THA
* severe back or knee pain
* rheumatology
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ZOL
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jens Vanbiervliet
Resident Orthopedic Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ZOL
Genk, Limburg, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16/076U
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.